Literature DB >> 28546450

Fatty acid binding protein 4/aP2-dependent BLT1R expression and signaling.

Ann V Hertzel1, Hongliang Xu1, Michael Downey1, Nicholas Kvalheim1, David A Bernlohr2.   

Abstract

Previous studies have shown that reduced levels of the adipocyte fatty acid binding protein (FABP)4 (AFABP/aP2), result in metabolic improvement including potentiated insulin sensitivity and attenuated atherosclerosis. Mechanistically, pharmacologic or genetic inhibition of FABP4 in macrophages upregulates UCP2, attenuates reactive oxygen species (ROS) production, polarizes cells toward the anti-inflammatory M2 state, and reduces leukotriene (LT) secretion. At the protein level, FABP4 stabilizes LTA4 toward chemical hydrolysis, thereby potentiating inflammatory LTC4 synthesis. Herein, we extend the FABP4-LT axis and demonstrate that genetic knockout of FABP4 reduces expression of the major macrophage LT receptor, LTB4 receptor 1 (BLT1R), via a ROS-dependent mechanism. Consistent with inflammation driving BLT1R expression, M1 polarized macrophages express increased levels of BLT1R relative to M2 polarized macrophages and treatment with proinflammatory lipopolysaccharide increased BLT1R mRNA and protein expression. In FABP4 knockout macrophages, silencing of UCP2, increased ROS levels and led to increased expression of BLT1R mRNA. Similarly, addition of exogenous H2O2 upregulated BLT1R expression, whereas the addition of a ROS scavenger, N-acetyl cysteine, decreased BLT1R levels. As compared with WT macrophages, LTB4-BLT1R-dependent JAK2-phosphorylation was reduced in FABP4 knockout macrophages. In summary, these results indicate that FABP4 regulates the expression of BLT1R and its downstream signaling via control of oxidative stress in macrophages.
Copyright © 2017 by the American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  adipocyte myelin P2; inflammation; leukotriene B4 receptor 1; leukotrienes; lipid mediators; lipids; macrophages; signal transduction

Mesh:

Substances:

Year:  2017        PMID: 28546450      PMCID: PMC5496033          DOI: 10.1194/jlr.M074542

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  74 in total

1.  Leukotriene B4 signaling through NF-kappaB-dependent BLT1 receptors on vascular smooth muscle cells in atherosclerosis and intimal hyperplasia.

Authors:  Magnus Bäck; De-xiu Bu; Robert Bränström; Yuri Sheikine; Zhong-Qun Yan; Göran K Hansson
Journal:  Proc Natl Acad Sci U S A       Date:  2005-11-17       Impact factor: 11.205

2.  Uncoupling lipid metabolism from inflammation through fatty acid binding protein-dependent expression of UCP2.

Authors:  Hongliang Xu; Ann V Hertzel; Kaylee A Steen; Qigui Wang; Jill Suttles; David A Bernlohr
Journal:  Mol Cell Biol       Date:  2015-01-12       Impact factor: 4.272

3.  Leukotriene B4 amplifies NF-κB activation in mouse macrophages by reducing SOCS1 inhibition of MyD88 expression.

Authors:  Carlos H Serezani; Casey Lewis; Sonia Jancar; Marc Peters-Golden
Journal:  J Clin Invest       Date:  2011-01-04       Impact factor: 14.808

4.  Inhibition of leukotriene B4-receptor interaction suppresses eosinophil infiltration and disease pathology in a murine model of experimental allergic encephalomyelitis.

Authors:  R P Gladue; L A Carroll; A J Milici; D N Scampoli; H A Stukenbrok; E R Pettipher; E D Salter; L Contillo; H J Showell
Journal:  J Exp Med       Date:  1996-04-01       Impact factor: 14.307

5.  Role of leukotriene B4 receptors in the development of atherosclerosis: potential mechanisms.

Authors:  Krishnaprasad Subbarao; Venkatakrishna R Jala; Steven Mathis; Jill Suttles; Wolfgang Zacharias; Jasimuddin Ahamed; Hydar Ali; Michael T Tseng; Bodduluri Haribabu
Journal:  Arterioscler Thromb Vasc Biol       Date:  2003-12-01       Impact factor: 8.311

6.  Fatty acid binding proteins stabilize leukotriene A4: competition with arachidonic acid but not other lipoxygenase products.

Authors:  Jennifer S Dickinson Zimmer; Douglas F Dyckes; David A Bernlohr; Robert C Murphy
Journal:  J Lipid Res       Date:  2004-09-01       Impact factor: 5.922

Review 7.  Lipid mediators in health and disease: enzymes and receptors as therapeutic targets for the regulation of immunity and inflammation.

Authors:  Takao Shimizu
Journal:  Annu Rev Pharmacol Toxicol       Date:  2009       Impact factor: 13.820

8.  LTB4 promotes insulin resistance in obese mice by acting on macrophages, hepatocytes and myocytes.

Authors:  Pingping Li; Da Young Oh; Gautam Bandyopadhyay; William S Lagakos; Saswata Talukdar; Olivia Osborn; Andrew Johnson; Heekyung Chung; Michael Maris; Jachelle M Ofrecio; Sayaka Taguchi; Min Lu; Jerrold M Olefsky
Journal:  Nat Med       Date:  2015-02-23       Impact factor: 53.440

Review 9.  Pharmacogenomics of Prostaglandin and Leukotriene Receptors.

Authors:  José A Cornejo-García; James R Perkins; Raquel Jurado-Escobar; Elena García-Martín; José A Agúndez; Enrique Viguera; Natalia Pérez-Sánchez; Natalia Blanca-López
Journal:  Front Pharmacol       Date:  2016-09-21       Impact factor: 5.810

10.  Reducing endoplasmic reticulum stress through a macrophage lipid chaperone alleviates atherosclerosis.

Authors:  Ebru Erbay; Vladimir R Babaev; Jared R Mayers; Liza Makowski; Khanichi N Charles; Melinda E Snitow; Sergio Fazio; Michelle M Wiest; Steven M Watkins; Macrae F Linton; Gökhan S Hotamisligil
Journal:  Nat Med       Date:  2009-11-29       Impact factor: 53.440

View more
  12 in total

Review 1.  Beyond adiponectin and leptin: adipose tissue-derived mediators of inter-organ communication.

Authors:  Jan-Bernd Funcke; Philipp E Scherer
Journal:  J Lipid Res       Date:  2019-06-17       Impact factor: 5.922

Review 2.  Mitochondrial Uncoupling Proteins: Subtle Regulators of Cellular Redox Signaling.

Authors:  Petr Ježek; Blanka Holendová; Keith D Garlid; Martin Jabůrek
Journal:  Antioxid Redox Signal       Date:  2018-03-14       Impact factor: 8.401

Review 3.  Adipokines, adiposity, and atherosclerosis.

Authors:  Longhua Liu; Zunhan Shi; Xiaohui Ji; Wenqian Zhang; Jinwen Luan; Tarik Zahr; Li Qiang
Journal:  Cell Mol Life Sci       Date:  2022-05-03       Impact factor: 9.261

4.  FABP4 regulates eosinophil recruitment and activation in allergic airway inflammation.

Authors:  Xiao Na Ge; Idil Bastan; Mythili Dileepan; Yana Greenberg; Sung Gil Ha; Kaylee A Steen; David A Bernlohr; Savita P Rao; P Sriramarao
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2018-04-26       Impact factor: 5.464

5.  [miR-203 inhibits lung cancer cell metastasis by targeting fatty acid binding protein 4].

Authors:  Ji-Chao Chen; Xu Wu
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2018-05-20

6.  Time-dependent, dynamic prediction of fatty acid-binding protein 4, Galectin-3, and soluble ST2 measurement with poor outcome after acute stroke.

Authors:  Christina Hansen; Cristina Sastre; Zoe Wolcott; Matthew B Bevers; W Taylor Kimberly
Journal:  Int J Stroke       Date:  2020-11-09       Impact factor: 6.948

7.  The anti-inflammatory agent bindarit acts as a modulator of fatty acid-binding protein 4 in human monocytic cells.

Authors:  Sergio Oddi; Lucia Scipioni; Antonio Totaro; Clotilde Angelucci; Beatrice Dufrusine; Annalaura Sabatucci; Daniel Tortolani; Isabella Coletta; Maria Alessandra Alisi; Lorenzo Polenzani; Michael Assfalg; Carlo Caltagirone; Enrico Dainese; Mauro Maccarrone
Journal:  Sci Rep       Date:  2019-10-22       Impact factor: 4.379

8.  Fatty acid-binding protein 4 silencing protects against lipopolysaccharide-induced cardiomyocyte hypertrophy and apoptosis by inhibiting the Toll-like receptor 4-nuclear factor-κB pathway.

Authors:  Fangyuan Sun; Gang Chen; Yingyao Yang; Ming Lei
Journal:  J Int Med Res       Date:  2021-03       Impact factor: 1.671

9.  Correlation of serum fatty acid binding protein-4 and interleukin-6 with airflow limitation and quality of life in stable and acute exacerbation of COPD

Authors:  Mohammad Reza Aslani; Zeynab Ghazaei; Hassan Ghobadi
Journal:  Turk J Med Sci       Date:  2020-04-09       Impact factor: 0.973

10.  Expression and correlation of Chemerin and FABP4 in peripheral blood of gestational diabetes mellitus patients.

Authors:  Xueling Wang; Juanjuan Liu; Dongqing Wang; Honghua Zhu; Le Kang; Juan Jiang
Journal:  Exp Ther Med       Date:  2019-11-26       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.